Summary
Background
Uroplakins (UPs), urothelium-specific transmembrane proteins, are present only in urothelia and may be good candidates as tumor markers specific for transitional cell carcinomas (TCCs). We investigated the expression of UP genes in the tissues and peripheral blood of patients with TCCs.
Materials and Methods
We determined the nucleotide sequences of UPs by a polymerase chain reaction (PCR)-based method. We then investigated UP gene expression in tissues from 12 patients with TCC by reverse transcription(RT)-PCR. We also investigated UP gene expression in peripheral blood of 12 other patients with TCC by nested RT-PCR. Polyclonal and monoclonal antibodies against UPs were generated using synthesized polypeptides and recombinant protein, respectively, as immunogens.
Results
We determined the nucleotide sequence of human UP-Ib, UP-II, and UP-HI cDNAs and produced gene-specific primer pairs for each and for UP-Ia. UP genes were expressed in both cancerous and non-cancerous urothelia taken from all patients examined (as detected by RT-PCR). The detection sensitivity of our assay system was such that 1 cancer cell could be detected in 5 mL of peripheral blood. UP gene-expression was also detected in the peripheral blood of 3 patients with metastatic TCC, but not from 9 patients with non-metastatic TCC or from 3 healthy volunteers. Antibodies against both UP-Ia and UP-Ib reacted with the cell membrane of TCCs.
Conclusions
UPs may be employed as tumor markers for TCCs, because they are highly conserved and well expressed in non-cancerous and cancerous cells. Furthermore, detection of UP gene expression in blood by nested RT-PCR may provide helpful information in the diagnosis and management of TCCs. We are currently expanding an immunohistochemical study by targeting a larger number of patients to examine the clinical usefulness of these antibodies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
The Japanese Urological Association, Japanese Pathological Society and Japan Radiological Society. General Rule for Clinical and Pathological Studies on Bladder Cancer. 2nd ed. Tokyo: Kanehara Co, 1993.
Lin JH, Wu XR, Kreibich G, Sun TT: Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane. J Biol Chem, 269:1775, 1994.
Minsky BD, Chlapowski FJ: Morphometric analysis of the translocation of transitional epithelial cells during the expansion-contraction cycles of mammalian urinary bladder. J Cell Biol, 77:685, 1978.
Moll R, Wu XR, Lin JH, Sun TT: Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Pathol 147:1383,1995.
Porter KR, Bonneville MA: An Introduction to the Fine Structure of Cells and Tissues. New York: Lea & Febiger, 1963.
Rasheed S, Gardner MB, Rongey RW, Nelson-Rees WA, Arnstein P: Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J Natl Cancer Inst, 58:881, 1977.
Sun TT, Zhao H, Provet J, Aebi U, Wu XR: Formation of asymmetric unit membrane during urothelial differentiation. Mol Biol Rep, 23:3, 1996.
Yoshiki T, Ueda M, Hirano A, Okada K, Yoshida O: Single-step purification of prostatic acid phosphatase: immunoaffinity chromatography with a monoclonal antibody. Int J Urol, 2:261, 1995.
Yu J, Manabe M, Wu XR, Xu C, Surya B, Sun TT: Uroplakin I: a 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium. J Cell Biol, 111:1207, 1990.
Yu J, Lin JH, Wu XR, Sun TT: Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J Cell Bio, 125:171, 1994.
Yuasa T, Yoshiki T, Tanaka T, Kim CJ, Isono T, Okada Y: Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma. Jpn J Cancer Res, 89:879, 1998.
Yuasa T, Yoshiki T, Isono T, Tanaka T, Hayashida H, Okada Y: Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients. Int J Urol, 6:286, 1999.
Wu XR, Sun TT: Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. J Cell Sci, 106:31, 1993.
Wu XR, Lin JH, Walz T, Haner M, Yu J, Aebi U, Sun TT: Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem, 269:13716, 1994.
Wu RL, Osman I, Wu XR, Lu ML, Zhang ZF, Liang FX, et al: Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res, 58:1291, 1998.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yuasa, T., Yoshiki, T., Isono, T., Tanaka, T., Okada, Y. (2003). Molecular Cloning and Expression of Uroplakins in Transitional Cell Carcinoma. In: Atala, A., Slade, D. (eds) Bladder Disease, Part A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8889-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8889-8_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4707-1
Online ISBN: 978-1-4419-8889-8
eBook Packages: Springer Book Archive